Invention Grant
- Patent Title: Cyclopropane carboxamide modulators of cystic fibrosis transmembrane conductance regulator
-
Application No.: US16225098Application Date: 2018-12-19
-
Publication No.: US10689370B2Publication Date: 2020-06-23
- Inventor: Chengzhi Zhang , Justin Chakma
- Applicant: Auspex Pharmaceuticals, Inc.
- Applicant Address: US PA North Wales
- Assignee: AUSPEX PHARMACEUTICALS, INC.
- Current Assignee: AUSPEX PHARMACEUTICALS, INC.
- Current Assignee Address: US PA North Wales
- Agency: BakerHostetler
- Main IPC: C07D405/12
- IPC: C07D405/12 ; A61K31/497 ; A61P11/00
Abstract:
The present invention relates to new cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions thereof, and methods of use thereof.
Public/Granted literature
- US20190367492A1 Cyclopropane Carboxamide Modulators of Cystic Fibrosis Transmembrane Conductance Regulator Public/Granted day:2019-12-05
Information query
